PAN: Pancreatic Cancer (Medicare)

Not Funded
About
The PAN: Pancreatic Cancer (Medicare) program offers comprehensive support for individuals undergoing treatment with approved drugs like Abraxane, Afinitor, and many others. By providing financial assistance for Medicare-covered prescription medications, PAN: Pancreatic Cancer (Medicare) ensures patients receive the necessary treatment without financial burden. The program facilitates easy enrollment and renewal processes, making it accessible and efficient for patients needing support with their medication expenses while fighting pancreatic cancer.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$3700 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note that this fund may cover offlabel drugs
Patients can either call (18663167263) or apply through selfservice patient portal
Provided patient completes application on self service portal or over the phone, eligibility determination takes less than one minute
Portal/representative will provide enrollment dates, the patient's PAN I.D. number and the available grant balance, allowing for medications to be dispensed
Patients will also receive approval letter and plastic pharmacy card within one week (provider will also receive letter)
Assistance begins on approval date and continues for 12 months
During initial eligibility period, eligible expenses incurred up to 90 days prior to approval date may also be submitted for reimbursement
All eligible expenses must be submitted within 120 days of the eligibility end date
Payment can be made to the patient, physician, pharmacy or health care provider
Patients are eligible for renewal at the end of their eligibility period if funds are available
Foundation will send a renewal application automatically if the program is accepting renewal patients
Patient may apply for a second grant during their eligibility period subject to availability of funding
Diagnosis Codes: ICD10: C25.0, C25.1, C25.2, C25.3, C25.4, C25.7, C25.8, C25.9, D13.6, D13.7